Company Performance - Abbott's stock closed at 1.34, indicating a 12.61% increase from the same quarter last year, with revenue forecasted at 4.67 per share and revenue of $42.01 billion, representing year-over-year growth of +5.18% and +4.73% respectively [3] Analyst Revisions - Recent revisions to analyst forecasts for Abbott are crucial as they reflect near-term business trends, with positive revisions indicating analyst optimism about the company's profitability [3][4] Zacks Rank and Valuation - Abbott currently holds a Zacks Rank of 3 (Hold), with a Forward P/E ratio of 25.47, which is lower than the industry average of 26.43 [5] - The company has a PEG ratio of 2.8, compared to the industry average of 2.37, indicating a higher anticipated earnings growth rate relative to its price [6] Industry Context - The Medical - Products industry, which includes Abbott, has a Zacks Industry Rank of 123, placing it in the top 49% of over 250 industries, suggesting a relatively strong performance [6][7]
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors